Matthew Walsh serves as the Executive Vice President and Chief Financial Officer at Organon, a global healthcare company focused on women's health. With over 25 years of experience in finance and business development, Walsh brings a wealth of knowledge and expertise to his role at Organon. Prior to joining the company, he held various leadership positions at Merck & Co., Inc., where he played a key role in the company's financial strategy and growth. At Merck, Walsh served as Vice President and Treasurer, overseeing the company's global treasury operations and financial risk management. He was instrumental in developing and implementing Merck's financial strategies, including capital allocation, debt management, and investor relations. Walsh's strong financial acumen and strategic vision were crucial in driving Merck's growth and profitability during his tenure. As EVP and CFO at Organon, Matthew Walsh is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, and investor relations. He plays a critical role in shaping Organon's financial strategy and ensuring the company's long-term growth and success. Walsh's extensive experience in the healthcare industry, coupled with his proven track record of financial leadership, make him an invaluable asset to Organon as the company continues to expand its portfolio of innovative women's health solutions.